Trial Type: Musculoskeletal

SWOGS2205
Ice Compress: Randomized Trial of Limb Cryocompression Versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuropathy
Protocol Status: OPEN TO ACCRUAL
Contact: Graff, Stephanie
ANBL1531
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Protocol Status: OPEN TO ACCRUAL
Contact: DeNardo, Bradley
ARST2032
A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
Protocol Status: OPEN TO ACCRUAL
Trial Type: Musculoskeletal
Contact: DeNardo, Bradley
AOST2032
A Feasibility and Randomized Phase 2/3 Study of the VEGFR2/MET Inhibitor Cabozantinib in Combination With Cytotoxic Chemotherapy for Newly Diagnosed Osteosarcoma
Protocol Status: OPEN TO ACCRUAL
Trial Type: Musculoskeletal
Contact: DeNardo, Bradley
BH-P-STOP
A Phase 1 Study of IM-1021 in Participants With Advanced Malignancies
Protocol Status: OPEN TO ACCRUAL
Contact: Olszewski, Adam
AOST2031
A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Protocol Status: OPEN TO ACCRUAL
Trial Type: Musculoskeletal
Contact: DeNardo, Bradley
EA7211
A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High Risk RetroPeritoneal Sarcoma (RPS)
Protocol Status: OPEN TO ACCRUAL
Trial Type: Musculoskeletal
Contact: Lagos, Galina
BH-P-CEDER
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of NDI-219216 in Patients With Advanced Solid Tumors With/Without Microsatellite Instability and/or Deficient Mismatch Repair
Protocol Status: OPEN TO ACCRUAL
Contact: Carneiro, Benedito
PHO-EXPANDEDACCESS-MIFAMURTIDE
Protocol Status: OPEN TO ACCRUAL
Trial Type: Musculoskeletal
Contact: DeNardo, Bradley
ANBL2131
A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma
Protocol Status: OPEN TO ACCRUAL
Contact: DeNardo, Bradley